ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

Targeting telomerase transcriptionally and posttranscriptionally using small molecules and anti-telomerase peptides: Potential double blow to aggressive drug resistant cancers

Implementing Organization

Institute of Genomics and Integrative Biology(IGIB), New Delhi
Principal Investigator
Dr. Shantanu Chowdhury
Scientist
|
Institute of Genomics and Integrative Biology(IGIB), New Delhi

Related Research

View All
Funding Organization
Funding Organization

—

Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Drug resistant cancer
Start Year
2017
Sanction Amount
₹ 65.52 L
Status
completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop